Forma Therapeutics Holdings (FMTX) Tops Q4 EPS by 12c

Forma Therapeutics Holdings (NASDAQ: FMTX) reported Q4 EPS of ($0.68), $0.12 better than the analyst estimate of ($0.80). Revenue for the quarter came in at $0 versus the consensus estimate of $200 thousand.

For earnings history and earnings-related data on Forma Therapeutics Holdings (FMTX) click here.

You May Also Be Interested In

• Growth isn't weak enough to truly undercut inflation pressures - BMO
• Fifth Third Bancorp (FITB) Tops Q1 EPS by 2c
• Lakeland Bancorp (LBAI) Tops Q1 EPS by 1c